Study Summary
The purpose of the study is to evaluate the safety and tolerability of B019 in subjects.
Want to learn more about this trial?
Request More InfoInterventions
B019BIOLOGICAL
B019： Intravenous infusion, 1.0×10\^6 CAR T cell/kg-10.0×10\^6 CAR T cell/kg
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Peking University People's Hospital | Beijing | China | |
| Jiangxi Province pediatric hospital | Nanchang | China | |
| The First Affiliated Hospital of Nanchang University | Nanchang | China | |
| Children's Hospital of Shanghai | Shanghai | China | |
| Shanghai Children's Medical Center | Shanghai | China | |
| Children's Hospital of Soochow University | Suzhou | China | |
| Tongji Hospital | Wuhan | China | |
| The Affiliated Hospital of Xuzhou Medical University | Xuzhou | China |